Current therapeutic options for colorectal liver metastases

doi:10.3877/cma.j.issn.1674-0793.2017.01.014

Abstract

Abstract:

Colorectal cancer is one of the most common malignant tumors, with its distant metastasis mainly to the liver. Currently, hepatectomy is the only safe and effective measure to cure colorectal liver metastasis (CLM), providing more than 50% 5-year-survival after the operation. In recent years, the diagnosis and treatment of CLM has been elevated with the improvement of chemotherapy, ablation, and radiotherapy. Comprehensive therapeutic schedule designed by appropriately integrating all the above-mentioned treatments exerts profound impact on the prognosis of CLM patients. This review attempts at summarizing the present status of CLM treatment.

Key words: Colorectal neoplasms, Neoplasm metastasis, Hepatectomy, Combined modality therapy

Sheng Wang, Chunzhao Yu. Current therapeutic options for colorectal liver metastases[J]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(01): 51-55.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2017.01.014

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2017/V11/I01/51

Figures/Tables 2

References 41

[1]	Siegel R,Naishadham D,Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
[2]	Biasco G,Derenzini E,Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties[J]. Cancer Treat Rev, 2006, 32(3): 214-228.
[3]	Jönsson K,Gröndahl G,Salö M, et al. Repeated liver resection for colorectal liver metastases: a comparison with primary liver resections concerning perioperative and long-term outcome[J]. Gastroenterol Res Pract, 2012, 2012: 568214.
[4]	Adam R,Hoti E,Bredt LC. Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?[J]. J Surg Oncol, 2010, 102(8): 922-931.
[5]	中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2015版)[J/CD]. 中华普通外科学文献（电子版）, 2015, 9(6): 506-523.
[6]	Hughes KS,Simon R,Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence[J]. Surgery, 1986, 100(2): 278-284.
[7]	Pawlik TM,Scoggins CR,Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases[J]. Ann Surg, 2005, 241(5): 715-722.
[8]	Yoo PS,Lopez-Soler RI,Longo WE, et al. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab[J]. Clin Colorectal Cancer, 2006, 6(3): 202-207.
[9]	Poston GJ,Figueras J,Giuliante F, et al. Urgent need for a new staging system in advanced colorectal cancer[J]. J Clin Oncol, 2008, 26(29): 4828-4233.
[10]	林俊忠,潘志忠. 结直肠癌肝转移外科治疗的争议[J]. 中华胃肠外科杂志, 2013, 16(8): 714-716.
[11]	李宇杰,车向明,甘建新, 等. 同时性结直肠癌肝转移同期与分期手术疗效的Meta分析[J]. 西安交通大学学报:医学版, 2012, 33(3): 365-369.
[12]	Cleary JM,Tanabe KT,Laywer GY, et al. Hepatic toxicities associated with the use of preoprative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver[J]. Oncologist, 2009, 14(11): 1095-1105.
[13]	吕文平,崔晓峰,蔡守旺, 等. 术中超声辅助肝切除联合射频消融根治性治疗双叶弥散性结直肠癌肝转移[J/CD]. 中华普外科手术学杂志（电子版）2012, 6(2): 21-23.
[14]	中华医学会外科学分会胃肠外科学组, 中华医学会外科学分会结直肠肛门外科学组, 中国抗癌协会大肠癌专业委员会, 等. 结直肠癌肝转移诊断和综合治疗指南（2016版）[J]. 中华消化外科杂志, 2016, 15(8): 755-767.
[15]	Waisberg J,Ivankovics IG. Liver-first approach of colorectal cancer with synchronous hepatic metastases: a reverse strategy[J]. World J Hepatol, 2015, 7(11): 1444-1449.
[16]	常颜信,杨家和. 结直肠癌肝转移的外科治疗现状与进展[J]. 国际外科学杂志, 2010, 37(2): 105-108.
[17]	Jones RP,Jackson R,Dunne DF, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases[J]. Br J Surg, 2012, 99(4): 477-486.
[18]	Rolff HC,Calatayud D,Larsen PN, et al. Good results after repeated resection for colorectal liver metastases[J]. Dan Med J, 2012, 59(2): A4373.
[19]	刘伟,闫晓峦,王崑, 等. 结直肠癌肝转移二次切除的预后分析[J]. 中华医学杂志, 2013, 93(28): 2183-2185.
[20]	Oussoultzoglou E,Romain B,Panaro F, et al. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens[J]. Ann Surg, 2009, 249(6): 879-886.
[21]	Pulitanò C,Bodingbauer M,Aldrighetti L, et al. Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection[J]. Ann Surg Oncol, 2012, 19(2): 435-442.
[22]	Wang DS,Louie JD,Sze DY. Intra-arterial therapies for metastatic colorectal cancer[J]. Semin Intervent Radiol, 2013, 30(1): 12-20.
[23]	Lordan JT,Karanjia ND,Quiney N, et al. A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting[J]. Eur J Surg Oncol, 2009, 35(3): 302-306..
[24]	徐达,邢宝才. 结直肠癌肝转移外科治疗策略[J]. 中国肿瘤临床, 2015, 42(17): 845-849.
[25]	Zdenkowski N,Chen S,van der Westhuizen A, et al. Curative strategies for liver metastases from colorectal cancer: a review[J]. Oncologist, 2012, 17(2): 201-211.
[26]	Cai GX,Cai SJ. Multi-modality treatment of colorectal liver metastases[J]. World J Gastroenterol, 2012, 18(1): 16-24.
[27]	乔天宇,徐永鹏,关旭, 等. 结直肠癌肝转移的治疗及预后因素分析[J]. 中华胃肠外科杂志, 2015, 18(9): 930-934.
[28]	National Comprehensive Cancer Network. The NCCN colorectal Cancer clinical practice guidelines in oncology (version 2.2016)[EB/OL]. [2016-09-27]. URL
[29]	Khan K,Wale A,Brown G, et al. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?[J]. World J Gastroenterol, 2014, 20(35): 12391-12406.
[30]	Bismuth H,Adam R,Lévi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy[J]. Ann Surg, 1996, 224(4): 509-520.
[31]	Folprecht G,Gruenberger T,Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial[J]. Lancet Oncol, 2010, 11(1): 38-47.
[32]	Loupakis F,Cremolini C,Masi G, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer[J]. N Engl J Med, 2014, 371(17): 1609-1618.
[33]	姚陈果,赵亚军,李成祥, 等. 不可逆电穿孔微创消融肿瘤技术的研究进展[J]. 高压电技术, 2014, 40(12): 3725-3737.
[34]	Ball C,Thomson KR,Kavnoudias H. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia[J]. Anesth Analg, 2010, 110(5): 1305-1309.
[35]	Joosten J,Ruers T. Local radiofrequency ablation techniques for liver metastases of colorectal cancer[J]. Crit Rev Oncol Hematol, 2007, 62(2): 153-163.
[36]	Wood TF,Rose DM,Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications[J]. Ann Surg Oncol, 2000, 7(8): 593-600.
[37]	Dodd GD 3rd,Frank MS,Aribandi M, et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations[J]. AJR Am J Roentgenol, 2001, 177(4): 777-782.
[38]	Nosher JL,Ahmed I,Patel AN, et al. Non-operative therapies for colorectal liver metastases[J]. J Gastrointest Oncol, 2015, 6(2): 224-240.
[39]	赵明,王健鹏,吴沛宏, 等. 射频消融治疗结直肠癌肝转移及其预后因素分析[J]. 中华医学杂志, 2010, 90(23): 1587-1592.
[40]	Chu KF,Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy[J]. Nat Rev Cancer, 2014, 14(3): 199-208.
[41]	Correa-Gallego C,Fong Y,Gonen M, et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases[J]. Ann Surg Oncol, 2014, 21(13): 4278-4283.

CT/MRI/PET部位肿瘤　大小生物学标准	肝外转移
CT/MRI/PET部位肿瘤　大小生物学标准	无	可切除	初始不可切除	不可切除
无肝转移		M2	M3	M4
肝转移可切除	M1a	M2a	M3a	M4a
肝转移初始不可切除	M1b	M2b	M3b	M4b
肝转移不可切除	M1c	M2c	M3c	M4c

CT/MRI/PET部位肿瘤　大小生物学标准	肝外转移
CT/MRI/PET部位肿瘤　大小生物学标准	无	可切除	初始不可切除	不可切除
无肝转移		M2	M3	M4
肝转移可切除	M1a	M2a	M3a	M4a
肝转移初始不可切除	M1b	M2b	M3b	M4b
肝转移不可切除	M1c	M2c	M3c	M4c

Please choose a citation manager

Content to export